Unicycive OLC received a second FDA CRL over third-party manufacturing deficiencies. The case shows why CMC risk now drives ...

At BIO 2026 in San Diego, Contract Pharma spoke with Zara Asgharpour, Head of External Innovation Integrated Biologics at ...

Taiwan’s Bora Group will shell out up to $127.5 million to acquire the CDMO business and manufacturing operations from Maryland-based MacroGenics. The deal calls for Bora to pay $122.5 million, with a ...

Demonstration batch production achieves all prespecified test specifications for dissolution, content uniformity, blend uniformity meeting regulatory requirements to start clinical drug product ...

The Centers for Disease Control and Prevention (CDC) has paused its diagnostic testing for a host of infectious diseases, including rabies. The CDC on Monday posted a list of 27 tests that it either ...

A social media post from the US Food and Drug Administration this week shows a big-eyed macaque staring out from behind bars. “Some drugs use 144 monkeys on average for preclinical testing,” the post ...

Forma Life Sciences Inc. today announced its launch as an independent contract development and manufacturing organization (CDMO). The new entity was formed through BioSelective Capital Investments’ ...

After promising to sell off 7% of its business back in November, Charles River Laboratories has delivered. The CRO is offloading its entire contract manufacturing operation and some of its European ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Wilmington company is ...

Charles River Laboratories is continuing its run of layoffs by announcing the closure of its cell therapy contract development and manufacturing organization (CDMO) site in Hanover, Maryland that will ...